samedan logo
 
 
spacer
home > epc > Spring 2016
PUBLICATIONS

European Pharmaceutical Contractor

epc
Spring 2016

   
Text
PDF
bullet
Marketplace & Business
Pricing and Market Access

People Skills


According to a-connect's Aunia Grogan and Claire Hempshall, it is vital to establish and maintain access to drugs in an evolving environment, which is characterised by tight budgets, shifting market trends and new therapy areas, among others.


 
view
download pdf
bullet
Marketplace & Business: Translation Feature
Translation Tools

Lingua Franca


Translation technology has grown in conjunction with the increasing number of clinical trials carried out globally. Trevor Korb at Corporate Translations wonders how these new tools can aid pharma.

 
view
download pdf
bullet
Legal & Regulatory
Clinical Evaluation

Conform to the Norm: Part 2


Continuing from EPC February, Terry Winchell at GCP Innovative Dynamics further elaborates on current regulations concerning clinical investigator disqualifications, and shares practical advice.

 
view
download pdf
bullet
Electronic Solutions
Patient Communication Technology

Talk Technical


Dr Mark Hooper at Conversis Medical Translations observes how technology has an impact on nearly all areas in the pharma industry, and that patient adherence, communication, enrolment and retention can be improved as a result.

 
view
download pdf

Medical Writing
Medical Writing Metrics

Do You Measure Up?


There is a pressing need to measure the performance of service providers for evaluation purposes, states Trilogy Writing & Consulting’s Dr Julia Forjanic Klapproth, while emphasising that metrics for medical writing are not simple to establish.

 
view
download pdf

Interview
Q&A: Electronic Patient-Reported Outcomes

Digital Approach

John Sage
at iCardiac tells EPC about the increasing demand for ePRO technologies, which opens up significant growth opportunities for developers of such innovations.

 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

Datwyler celebrates official opening of its new production plant with First Line standard in Middletown, Del

• The new facility in Middletown, Del., is Datwyler’s third facility with First Line standard which will be catering to the markets in North and South America • Approximately 120 jobs will be created, with the majority staffed from the local community • With the Middletown facility, Datwyler will be able to increase its global First Line production by 50 percent by 2020 • First Line is specially designed to manufacture biotech and pharmaceutical elastomer components in a fully integrated good manufacturing practice (GMP) environment
More info >>

White Papers

Is Your Biobank Ready for the Challenge of Biomarker-based Research?

BioFortis

Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems.  Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
More info >>

Industry Events

Biotech Showcase™ 2019

7-9 January 2019, Hilton San Francisco Union Square

Biotech Showcase™ is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement